114 related articles for article (PubMed ID: 35986882)
21. Role of the tripartite motif protein 27 in cancer development.
Zoumpoulidou G; Broceño C; Li H; Bird D; Thomas G; Mittnacht S
J Natl Cancer Inst; 2012 Jun; 104(12):941-52. PubMed ID: 22556269
[TBL] [Abstract][Full Text] [Related]
22. Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation.
Chen SY; Zhang HP; Li J; Shi JH; Tang HW; Zhang Y; Zhang JK; Wen PH; Wang ZH; Shi XY; He YT; Hu BW; Yang H; Guo WZ; Zhang SJ
Hepatology; 2021 Feb; 73(2):738-758. PubMed ID: 32343849
[TBL] [Abstract][Full Text] [Related]
23. USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression.
Li B; Wang B
Immunol Invest; 2022 Oct; 51(7):1921-1937. PubMed ID: 35852892
[TBL] [Abstract][Full Text] [Related]
24. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
25. TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling.
Liu S; Tian Y; Zheng Y; Cheng Y; Zhang D; Jiang J; Li S
Aging (Albany NY); 2020 Dec; 12(24):25564-25580. PubMed ID: 33264103
[TBL] [Abstract][Full Text] [Related]
26. TRIM28 and TRIM27 are required for expressions of PDGFRβ and contractile phenotypic genes by vascular smooth muscle cells.
Wang Y; Hao Y; Zhao Y; Huang Y; Lai D; Du T; Wan X; Zhu Y; Liu Z; Wang Y; Wang N; Zhang P
FASEB J; 2020 May; 34(5):6271-6283. PubMed ID: 32162409
[TBL] [Abstract][Full Text] [Related]
27. PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway.
Li H; Zhang X; Song X; Zhu F; Wang Q; Guo C; Liu C; Shi Y; Ma C; Wang X; Zhang L
Cancer Biol Ther; 2012 Jul; 13(9):822-30. PubMed ID: 22688731
[TBL] [Abstract][Full Text] [Related]
28. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
[TBL] [Abstract][Full Text] [Related]
29. TRIM27-mediated ubiquitination of PPARγ promotes glutamate-induced cell apoptosis and inflammation.
Hao Y; Bai S; Peng J; Hong R; Ding J; Li Z; Guan Y
Exp Cell Res; 2021 Mar; 400(1):112437. PubMed ID: 33385414
[TBL] [Abstract][Full Text] [Related]
30. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
31. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
32. [RAD51 promotes proliferation and migration of glioblastoma cells and decreases sensitivity of cells to temozolomide].
Li Q; Ru Y; Wang Q; Lyu W; Hu W; Fei Z; Li X; Lin W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Sep; 35(9):817-822. PubMed ID: 31750824
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner.
Cai Y; Gu WT; Cheng K; Jia PF; Li F; Wang M; Zhang WF; Qiu JT; Wu ZB; Zhao WG
Biochem Biophys Res Commun; 2021 Apr; 550():134-141. PubMed ID: 33691199
[TBL] [Abstract][Full Text] [Related]
34. TRIM27 expression is associated with poor prognosis in sinonasal mucosal melanoma.
Kimura S; Suzuki M; Nakamaru Y; Kano S; Watanabe M; Honma A; Nakazono A; Tsushima N; Hatakeyama S; Homma A
Rhinology; 2023 Jun; 61(3):263-271. PubMed ID: 36891983
[TBL] [Abstract][Full Text] [Related]
35. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
36. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.
Han S; Li Z; Master LM; Master ZW; Wu A
Br J Cancer; 2014 Sep; 111(7):1400-9. PubMed ID: 25093489
[TBL] [Abstract][Full Text] [Related]
37. Identification of immunogenic MAGED4B peptides for vaccine development in oral cancer immunotherapy.
Lim KP; Chun NA; Gan CP; Teo SH; Rahman ZA; Abraham MT; Zain RB; Ponniah S; Cheong SC
Hum Vaccin Immunother; 2014; 10(11):3214-23. PubMed ID: 25483651
[TBL] [Abstract][Full Text] [Related]
38. TRIM27 promotes the development of esophagus cancer via regulating PTEN/AKT signaling pathway.
Ma L; Yao N; Chen P; Zhuang Z
Cancer Cell Int; 2019; 19():283. PubMed ID: 31719796
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of hSNF2H in glioma promotes cell proliferation, invasion, and chemoresistance through its interaction with Rsf-1.
Zhao XC; An P; Wu XY; Zhang LM; Long B; Tian Y; Chi XY; Tong DY
Tumour Biol; 2016 Jun; 37(6):7203-12. PubMed ID: 26666816
[TBL] [Abstract][Full Text] [Related]
40. PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.
Higuchi F; Fink AL; Kiyokawa J; Miller JJ; Koerner MVA; Cahill DP; Wakimoto H
Mol Cancer Ther; 2018 Dec; 17(12):2551-2563. PubMed ID: 30217967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
